1. Home
  2. TECX vs RR Comparison

TECX vs RR Comparison

Compare TECX & RR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.02

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$2.14

Market Cap

614.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
RR
Founded
2019
2016
Country
United States
United States
Employees
60
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
549.5M
614.9M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
TECX
RR
Price
$30.02
$2.14
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$75.20
$4.00
AVG Volume (30 Days)
132.7K
12.2M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,045,000.00
Revenue This Year
N/A
$75.68
Revenue Next Year
N/A
$78.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.99
52 Week Low
$14.39
$1.73
52 Week High
$35.99
$7.43

Technical Indicators

Market Signals
Indicator
TECX
RR
Relative Strength Index (RSI) 54.28 39.46
Support Level $27.31 $1.85
Resistance Level $31.39 $2.93
Average True Range (ATR) 1.89 0.21
MACD 0.12 -0.07
Stochastic Oscillator 71.39 7.56

Price Performance

Historical Comparison
TECX
RR

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

Share on Social Networks: